Related references
Note: Only part of the references are listed.Challenges in the current antiangiogenic treatment paradigm for patients with non-small cell lung cancer
Antoinette Wozniak
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway
Yao Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Staging and Prognosis of Cutaneous Melanoma
Paxton V. Dickson et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2011)
2010 TNM Staging System for Cutaneous MelanomaaEuro¦and Beyond
Jeffrey E. Gershenwald et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
A Mouse Model of Melanoma Driven by Oncogenic KRAS
Carla Milagre et al.
CANCER RESEARCH (2010)
Glioblastoma stem-like cells give rise to tumour endothelium
Rong Wang et al.
NATURE (2010)
c-Kit mutants require hypoxia-inducible factor 1α to transform melanocytes
G. Monsel et al.
ONCOGENE (2010)
Focal amplification and oncogene dependency of GAB2 in breast cancer
M. Bocanegra et al.
ONCOGENE (2010)
Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation
P. J. Mishra et al.
ONCOGENE (2010)
VEGF and endothelial guidance in angiogenic sprouting
Holger Gerhardt
Organogenesis (2010)
Gab2-Mediated Signaling Promotes Melanoma Metastasis
Basil Horst et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Function, regulation and pathological roles of the Gab/DOS docking proteins
Franziska U. Woehrle et al.
CELL COMMUNICATION AND SIGNALING (2009)
Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells
Christine Caron et al.
CELLULAR SIGNALLING (2009)
GAB2 Amplifications Refine Molecular Classification of Melanoma
Karen A. Chernoff et al.
CLINICAL CANCER RESEARCH (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Amplification of 11q13 in ovarian carcinoma
Lindsay A. Brown et al.
GENES CHROMOSOMES & CANCER (2008)
Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-kit
Jianmin Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Notch signaling regulates tumor angiogenesis by diverse mechanisms
J. Dufraine et al.
ONCOGENE (2008)
Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis
H. L. Bennett et al.
ONCOGENE (2008)
Role of Gab2 in mammary tumorigenesis and metastasis
Y. Ke et al.
ONCOGENE (2007)
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
Linan Ha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Shp2 in PC12 cells: NGF versus EGF signalling
Amelia D'Alessio et al.
CELLULAR SIGNALLING (2007)
The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation
Melanie Laramee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
GAB2 is a novel target of 11q amplification in AML/MDS
Andrea Zatkova et al.
GENES CHROMOSOMES & CANCER (2006)
The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase
Marie Dance et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity
Carlotta Petti et al.
CANCER RESEARCH (2006)
Imatinib mesylate inhibits proliferation of rheumatoid synovial fibroblast-like cells and phosphorylation of Gab adapter proteins activated by platelet-derived growth factor
H Kameda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
A role for the scaffolding adapter GAB2 in breast cancer
M Bentires-Alj et al.
NATURE MEDICINE (2006)
Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor
SS Meng et al.
BIOCHEMICAL JOURNAL (2005)
A novel role for Gab2 in bFGF-mediated cell survival during retinoic acid-induced neuronal differentiation
YW Mao et al.
JOURNAL OF CELL BIOLOGY (2005)
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations
Y Chudnovsky et al.
NATURE GENETICS (2005)
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background
J Ackermann et al.
CANCER RESEARCH (2005)
Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B
C Berking et al.
CANCER RESEARCH (2004)
Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma
MJC Hendrix et al.
NATURE REVIEWS CANCER (2003)
The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors
K Nishida et al.
CANCER SCIENCE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Critical role for Gab2 in transformation by BCR/ABL
M Sattler et al.
CANCER CELL (2002)
Dual inactivation of RB and p53 pathways in RAS-induced melanomas
N Bardeesy et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)